About this trial

To prospectively assess the incidence of peritoneal carcinomatosis for women with isolated STIC (serous tubal intraepithelial carcinoma). Moreover, to identify histopathological characteristics of STIC which are reproducible and associated to the risk of peritoneal carcinomatosis and to report the findings of additional diagnostics.

Eligibility criteria

Qualifiers

Women

Bilateral salpingectomy (with or without oophorectomy)

A serous tubal intraepithelial carcinoma at histopathological review

Disqualifiers

Invasive cancer at initial surgery or pathological examination (either macroscopic and/or microscopic)

Trial design

Treatments tested in this trial

  • No intervention, only registration

Treatment groups

600 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Radboud University Medical Center

Lead sponsor